Health catalyst, inc. (HCAT)
Income statement / Yearly
Dec'19Dec'18Dec'17
Revenue:
Revenue

154,941

112,574

73,081

Cost of revenue, excluding depreciation and amortization:
Total cost of revenue, excluding depreciation and amortization

75,345

59,852

43,642

Operating expenses:
Sales and marketing

47,284

44,123

25,920

Research and development

46,252

38,592

28,470

General and administrative

31,713

22,690

14,697

Depreciation and amortization

9,212

7,412

5,892

Total operating expenses

134,461

112,817

74,979

Loss from operations

-54,865

-60,095

-45,540

Loss on extinguishment of debt

-1,670

0

0

Interest and other expense, net

3,419

2,024

1,469

Net loss before income taxes

-59,954

-62,119

-47,009

Income tax (benefit) provision

142

-135

26

Net loss

-60,096

-61,984

-47,035

Less: accretion of redeemable convertible preferred stock

180,826

52,037

11,745

Net loss attributable to common stockholders

-240,922

-114,021

-58,780

Net loss per share attributable to common stockholders, basic and diluted (in USD per share)

-12.86

-23.76

-12.13

Weighted-average number of shares used in calculating net loss per share attributable to common stockholders, basic and diluted (in shares)

18,741

4,798

4,846

Technology
Revenue

83,975

57,224

31,693

Total cost of revenue, excluding depreciation and amortization

27,797

19,429

11,610

Professional services
Revenue

70,966

55,350

41,388

Total cost of revenue, excluding depreciation and amortization

47,548

40,423

32,032